News
The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...
Researchers at The Institute of Cancer Research, London, have uncovered a hidden weakness in some breast cancer tumours that could lead to smarter treatment decisions. One of the body’s natural ...
The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA). The approval ...
Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...
In April 2019, Claire Shepherd, now 34, began feeling unwell and constantly fatigued. Having initially put her symptoms down to her hectic lifestyle, she was shocked to be diagnosed with acute myeloid ...
Give a monthly donation to help us stay one step ahead of cancer with new smarter and targeted treatments – so that more people will survive blood cancer. Cecelia Brunott (pictured above) was ...
We are delighted to host this event, bringing together representatives from various organisations who work closely with science apprentices. The conference will be held on 15 th of May 2025 at the ...
Victoria Cushing earned her Master's degree in biochemistry from the University of Oxford. She is investigating the structure and function of CAK and is currently pursuing high-resolution structures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results